These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30360937)

  • 1. Noninvasive real-time assessment of riboflavin consumption in standard and accelerated corneal crosslinking.
    Lombardo M; Lombardo G
    J Cataract Refract Surg; 2019 Jan; 45(1):80-86. PubMed ID: 30360937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrastromal application of riboflavin for corneal crosslinking.
    Seiler TG; Fischinger I; Senfft T; Schmidinger G; Seiler T
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4261-5. PubMed ID: 24917136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between standard and transepithelial corneal crosslinking using a theranostic UV-A device.
    Lombardo G; Serrao S; Lombardo M
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):829-834. PubMed ID: 31900647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-Optical Method to Assess Stromal Concentration of Riboflavin in Conventional and Accelerated UV-A Irradiation of the Human Cornea.
    Lombardo G; Micali NL; Villari V; Serrao S; Lombardo M
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):476-83. PubMed ID: 26868750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic Resistance of Corneas Crosslinked Using Riboflavin in Conjunction With Low Energy, High Energy, and Pulsed UVA Irradiation Modes.
    Aldahlawi NH; Hayes S; O'Brart DP; Akhbanbetova A; Littlechild SL; Meek KM
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1547-52. PubMed ID: 27046119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the riboflavin film in corneal collagen crosslinking.
    Wollensak G; Aurich H; Wirbelauer C; Sel S
    J Cataract Refract Surg; 2010 Jan; 36(1):114-20. PubMed ID: 20117714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of stromal riboflavin concentration-depth profile in nanotechnology-based transepithelial corneal crosslinking.
    Lombardo G; Micali NL; Villari V; Leone N; Serrao S; Rusciano D; Lombardo M
    J Cataract Refract Surg; 2017 May; 43(5):680-686. PubMed ID: 28602332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous-light versus pulsed-light accelerated corneal crosslinking with ultraviolet-A and riboflavin.
    Zhu Y; Reinach PS; Zhu H; Li L; Yang F; Qu J; Chen W
    J Cataract Refract Surg; 2018 Mar; 44(3):382-389. PubMed ID: 29703291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Study of Collagen Cross-Linking With Conventional Versus Accelerated UVA Irradiation Using Riboflavin With Hydroxypropyl Methylcellulose: Two-Year Results.
    Hagem AM; Thorsrud A; Sandvik GF; Drolsum L
    Cornea; 2019 Feb; 38(2):203-209. PubMed ID: 30365412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Corneal Density After Accelerated Corneal Collagen Cross-linking With Different Irradiation Intensities and Energy Exposures: 1-Year Follow-up.
    Akkaya Turhan S; Toker E
    Cornea; 2017 Nov; 36(11):1331-1335. PubMed ID: 28872519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of riboflavin-UVA cross-linking and "flash-linking" using surface wave elastometry.
    Rocha KM; Ramos-Esteban JC; Qian Y; Herekar S; Krueger RR
    J Refract Surg; 2008 Sep; 24(7):S748-51. PubMed ID: 18811123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet A: Visible spectral absorbance of the human cornea after transepithelial soaking with dextran-enriched and dextran-free riboflavin 0.1% ophthalmic solutions.
    Lombardo M; Micali N; Villari V; Serrao S; Pucci G; Barberi R; Lombardo G
    J Cataract Refract Surg; 2015 Oct; 41(10):2283-90. PubMed ID: 26703306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of UVA Cytotoxicity for Human Endothelium in an Ex Vivo Corneal Cross-linking Experimental Setting.
    Mooren P; Gobin L; Bostan N; Wouters K; Zakaria N; Mathysen DG; Koppen C
    J Refract Surg; 2016 Jan; 32(1):41-6. PubMed ID: 26812713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances.
    Hammer A; Richoz O; Arba Mosquera S; Tabibian D; Hoogewoud F; Hafezi F
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2881-4. PubMed ID: 24677109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal light backscattering after transepithelial corneal crosslinking using iontophoresis in donor human corneal tissue.
    Lombardo M; Serrao S; Carbone G; Lombardo G
    J Cataract Refract Surg; 2015 Mar; 41(3):635-43. PubMed ID: 25804584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Multimodal Microscopy, Tissue Morphology, and Enzymatic Resistance in Riboflavin-UVA Cross-Linked Human Corneas.
    Laggner M; Pollreisz A; Schmidinger G; Byrne RA; Scheinecker C; Schmidt-Erfurth U; Chen YT
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3584-92. PubMed ID: 26047045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal stromal demarcation line after accelerated crosslinking using continuous and pulsed light.
    Moramarco A; Iovieno A; Sartori A; Fontana L
    J Cataract Refract Surg; 2015 Nov; 41(11):2546-51. PubMed ID: 26703505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative treatment of keratoconus by riboflavin-uva-induced cross-linking of corneal collagen: qualitative investigation.
    Mazzotta C; Traversi C; Baiocchi S; Sergio P; Caporossi T; Caporossi A
    Eur J Ophthalmol; 2006; 16(4):530-5. PubMed ID: 16952090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Corneal Riboflavin Gradients Using Dextran and HPMC Solutions.
    Ehmke T; Seiler TG; Fischinger I; Ripken T; Heisterkamp A; Frueh BE
    J Refract Surg; 2016 Dec; 32(12):798-802. PubMed ID: 27930789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomechanical efficacy of corneal cross-linking using hypoosmolar riboflavin solution.
    Wollensak G; Spörl E
    Eur J Ophthalmol; 2019 Sep; 29(5):474-481. PubMed ID: 30255714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.